A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell Disease
Clinical trial NCT01597401 · COMPLETED
Trial details
- NCT number
- NCT01597401
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-12
- Primary completion
- 2013-06-07
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.